These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9304708)

  • 1. Applications of gene transfer in hematologic malignancy.
    Brenner MK
    Recent Results Cancer Res; 1998; 144():60-9. PubMed ID: 9304708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging applications of gene transfer in the hematopoietic cancers.
    Brenner MK
    J Pediatr Hematol Oncol; 1997; 19(1):1-6. PubMed ID: 9065713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene therapy of malignant hematologic diseases].
    Porkka K
    Duodecim; 1998; 114(12):1275-85. PubMed ID: 11524774
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene transfer for the therapy of hematologic malignancy.
    Heslop HE; Roskrow M
    Curr Opin Hematol; 1995 Nov; 2(6):417-22. PubMed ID: 9372030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer and the treatment of haematological malignancy.
    Brenner MK
    J Intern Med; 2001 Apr; 249(4):345-58. PubMed ID: 11298855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological malignancies.
    Brenner MK
    FASEB J; 1997 Jul; 11(8):640-8. PubMed ID: 9240966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy of hematologic malignancies.
    Wierda WG; Kipps TJ
    Semin Oncol; 2000 Oct; 27(5):502-11. PubMed ID: 11049018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance.
    Koç ON; Allay JA; Lee K; Davis BM; Reese JS; Gerson SL
    Semin Oncol; 1996 Feb; 23(1):46-65. PubMed ID: 8607032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer in haematological malignancy.
    Brenner MK
    Ann Med; 1996 Dec; 28(6):491-7. PubMed ID: 9017108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular immunotherapy for hematological malignancies].
    Yasukawa M
    Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hematological malignancy-associated antigens and clinical applications.
    Fujiwara H
    Rinsho Ketsueki; 2009 May; 50(5):340-51. PubMed ID: 19483393
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprotection by transfer of resistance genes.
    Budak-Alpdogan T; Bertino JR
    Methods Mol Biol; 2009; 542():661-704. PubMed ID: 19565927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo.
    Licht T; Gottesman MM; Pastan I
    Cytokines Mol Ther; 1995 Mar; 1(1):11-20. PubMed ID: 9384659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy of pediatric leukemia.
    Heslop HE
    Clin Lab Med; 2000 Mar; 20(1):183-95, x. PubMed ID: 10702902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy.
    Hanazono Y; Terao K; Ozawa K
    Stem Cells; 2001; 19(1):12-23. PubMed ID: 11209087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Will transfer of cytostatic drug resistance genes increase hematopoiesis resistance in the treatment of malignant tumors?].
    Jelínek J; Fairbairn LJ; Dexter TM; Rafferty JA; Stocking C; Baum C; Ostertag W; Margison GP
    Cas Lek Cesk; 1997 Jan; 136(1):22-6. PubMed ID: 9147848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.
    van der Veken LT; Hoogeboom M; de Paus RA; Willemze R; Falkenburg JH; Heemskerk MH
    Gene Ther; 2005 Dec; 12(23):1686-95. PubMed ID: 16034453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.